Recombinant MLANA antibody
Quick Overview for Recombinant MLANA antibody (ABIN3025217)
Target
See all MLANA AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purification
- Protein A affinity chromatography
-
Immunogen
- Recombinant human protein was used as the immunogen for this MART-1 antibody.
-
Isotype
- IgG kappa
-
-
-
-
Application Notes
-
The optimal dilution of the MART-1 antibody for each application should be determined by the researcher.
1. Staining of formalin-fixed tissues is enhanced by boiling tissue sections in 10 mM Citrate Buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes.\. FACS: 0.5-1 μg/10^6 cells, Immunofluorescence: 0.5-1 μg/mL,Immunohistochemistry (FFPE): 0.5-1 μg/mL for 30 minutes at RT (1)
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Preservative
- Azide free
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store the MART-1 antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
-
-
- MLANA (Melan A (MLANA))
-
Alternative Name
- MART-1
-
Background
- MART-1/Melan-A is a protein antigen that is found on the surface of melanocytes. Antibodies against the antigen are used in the medical specialty of anatomic pathology in order to recognize cells of melanocytic differentiation, useful for the diagnosis of a melanoma. The MART-1/Melan-A antigen is specific for the melanocyte lineage, found in normal skin, the retina, and melanocytes, but not in other normal tissues. It is thus useful as a marker for melanocytic tumors (melanomas) with the caveat that it is normally found in benign nevi as well. [Wiki]
Target
-